What You Should Know:
Data Driven Insights Enabled by Merck and Amgen Fundings
As the most extensive repository of its kind, this data lake empowers biopharmaceutical companies by providing crucial insights necessary for advancing diagnostic and…
Continue Reading
Vivodyne started as an idea between Co-Founders Andrei Georgescu (left), now Vivodyne’s CEO, and UPenn Professor Dan Huh (right), now Vivodyne’s CSO, while Andrei performed his Ph.D. graduate studies in Huh’s bioengineering research lab….
Continue Reading
In the highly competitive life sciences, biotechnology, and pharmaceutical fields, companies that put data security first have powerful advantages. Robust security is the heart of medical innovation, enabling the groundbreaking research required to develop…
Continue Reading
What You Should Know:
– Boehringer Ingelheim and IBM announced a collaboration to leverage IBM’s foundation model technologies for the discovery of novel candidate antibodies in drug development.
– The partnership will focus on utilizing IBM’s…
Continue Reading
The demand for ambient clinical voice solutions is gaining momentum and the market is quickly filling with vendors. Microsoft Nuance has been providing healthcare voice solutions for over two decades. How is the company…
Continue Reading
The demand for ambient clinical voice solutions is gaining momentum and the market is quickly filling with vendors. Microsoft Nuance has been providing healthcare voice solutions for over two decades. How is the company…
Continue Reading
What You Should Know:
– Genentech and NVIDIA today announced a multi-year strategic research collaboration that couples Genentech’s artificial intelligence (AI) capabilities, extensive biological and molecular datasets, and research expertise with NVIDIA’s world-leading accelerated computing…
Continue Reading
What You Should Know:
– AstraZeneca, a global biopharmaceutical company, has announced the launch of Evinova, a new business venture dedicated to providing cutting-edge digital health solutions that address the evolving needs of healthcare professionals,…
Continue Reading
Cleerly, a leading innovator in the field of cardiovascular disease diagnosis, today announced the launch of the TRANSFORM trial at the American Heart Association’s (AHA) 2023 Scientific Sessions. This groundbreaking trial aims to revolutionize…
Continue Reading
Sabrina Steffen, Head of Data Strategy and Innovation for Data Management at IQVIA
In drug development, there is a critical focus on protocol design, because it is a key component to running a successful clinical…
Continue Reading
